News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Wendy Luo

Advertisement

Wendy Luo is an associate director, Drug Safety Evaluation, Bristol-Myers Squibb;

Articles by Wendy Luo

EMA Guideline on Setting Health-Based Exposure Limits

ByAndrew Teasdale,Laura Rutter,Courtney M. Callis,Bruce D. Naumann,Gretchen Allison,Wendy Luo,Bryan K. Shipp,Christopher Seaman
December 2nd 2015

The results of an industry workgroup’s examination of EMA’s guide on shared facilities are presented.

Advertisement

Latest Updated Articles

  • EMA Guideline on Setting Health-Based Exposure Limits
    EMA Guideline on Setting Health-Based Exposure Limits

    Published: December 2nd 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

CPHI Frankfurt 2025: Regulatory Challenges for Global Manufacturing of Vaccines

2

AI and Accelerated Computing Propel the Biopharma Ecosystem Forward

3

Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts

4

Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One

5

Why Sound Science Is Pharma's Best Defense Against Regulatory Shifts

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us